摘要:
The invention concerns an in vitro method for the diagnosis and/or prognosis and/or assessment of the development of a chronic inflammatory lung disease in a patient, using the expression level of the receptor gene coupled to GPR15 G proteins as a biomarker of the disease.
摘要:
The invention concerns the use of a collection of traceable cationic compounds for determining ligands of a receptor whose ligand is unknown or whose ligand useful for specific affinity binding studies is unknown, said traceable cationic compounds being characterized in that they comprise at least one basic amino acid residue providing the cationic type to said compound and a tracer group, in particular a fluorophor, a colouring agent or a quencher.
摘要:
The invention concerns the use of a fluorescent protein selected in particular among the autofluorescent proteins for detecting the non-covalent interaction between a target protein marked by the fluorescent protein and one of its ligands marked by a marker consisting of: either a molecule capable of absorbing the light emitted by the fluorescent protein, or a fluorescent substance, said detection taking place by fluorescence energy transfer: between the fluorescent protein and said fluorescent substance, the fluorescent substance being such that it is excitable at the fluorescent protein emitting wavelength, or it emits at the fluorescent protein emitting wavelength; between the fluorescent protein and said molecule capable of absorbing the light emitted by the fluorescent protein.
摘要:
The invention relates to the cosmetic or pharmaceutical use of a composition containing a derivative of nicotinic or salicylic acid that inhibits chemokines, in order to prevent or treat internal and/or external chronic inflammatory disorders.
摘要:
The invention relates to the cosmetic or pharmaceutical use of a composition containing a derivative of theophylline of formula (I) that inhibits chemokines, in order to prevent or treat internal and/or external chronic inflammatory disorders. R represents an alkyl, cycloalkyl or alkenyl group in which at least one -CH 2 - group can be replaced by -O- or substituted by at least one radical selected from among the alkyl, hydroxy and alkoxy radicals.